Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607659 · ClinicalTrials.gov registry record
Immunopathogenesis of Chlamydia
A clinical trial of Chlamydia Infections, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT00607659: Completed study of Chlamydia Infections, sponsored by Arkansas Children's Hospital Research Institute.
NCT00607659 is a study of Chlamydia Infections that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607659, a study of Chlamydia Infections, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factors for adverse outcomes following genital tract infection with Chlamydia trachomatis and to evaluate whether or not the presence of C. trachomatis in the rectum act as a reservoir for infection.
Conditions Studied
Interventions
- OTHER No intervention, only observational
Study Locations (1)
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2008-01 |
| Est. Completion | 2016-01 |
What the finished NCT00607659 record still lists
NCT00607659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 1 condition, with Chlamydia Infections appearing as the primary indexed condition, and to 1 intervention - of which No intervention, only observational is the first listed.
NCT00607659 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT00607659 about?
NCT00607659 is a clinical study titled "Immunopathogenesis of Chlamydia". Sexually transmitted Chlamydia trachomatis infections are a widespread public health concern due to their prevalence and potentially devastating reproductive consequences, including pelvic inflammatory disease, infertility, and ectopic pregnancy. The goal of this study is to evaluate the risk factor...
What is the current status of trial NCT00607659?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2008-01. Estimated completion is 2016-01.
What conditions does trial NCT00607659 study?
This clinical trial studies the following conditions: Chlamydia Infections.
What interventions are being tested in trial NCT00607659?
The interventions under investigation include: No intervention, only observational (OTHER).
Who is sponsoring clinical trial NCT00607659?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00607659 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chlamydia Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia